CNS Pharmaceuticals’ Webinar – November 2020

Disclaimer: The views and opinions expressed by Robert LeBoyer, Managing Director of Equity Research, Ladenburg Thalmann & Co., Inc., are those of Mr. LeBoyer exclusively and do not necessarily reflect the views or opinions of CNS Pharmaceuticals, Inc. (the ‘Company”). The Company is not responsible for such views or opinions and can offer no assurance that actual performance and events will not differ from such views and opinions.

Join Our Newsletter To Follow Our Progress!